| 000 | 01862cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030937.0 | ||
| 008 | 140226s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.18.Ph.D.2013.Ma.E | ||
| 100 | 0 | _aMazen Ahmed Attia Taha | |
| 245 | 1 | 0 |
_aEnd glycated proteins in pregnant diabetics with pregnancy induced hypertension / _cMazen Ahmed Attia Taha ; Supervised Ali Mamdouh Elashmawy , Hebat Allah Moustafa , Ahmed Soliman Nasr |
| 246 | 1 | 5 | _aالبروتينات السكريه المنتهيه فى مرضى السكر الحوامل مع ارتفاع ضغط الدم المصاحب للحمل |
| 260 |
_aCairo : _bMazen Ahmed Attia Taha , _c2013 |
||
| 300 |
_a121 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aMajor congenital malformations are the leading cause of mortality and morbidity in infants of mothers with type 1 or 2 diabetes. Several studies have established an association between elevated maternal glucose or glycated hemoglobin (HbA1C) levels during embryogenesis and high rates of spontaneous abortions. We studied the levels of end glycated proteins in pregnant diabetics with pregnancy induced hypertension (PIH) and the relation of levels of (HbA1C) to fetal and placental blood flow in these patients | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDiabetes mellitus | |
| 653 | 4 | _aHbA{u2160}C | |
| 653 | 4 | _aP{u2160}H | |
| 700 | 0 |
_aAhmed Soliman Nasr , _eSupervisor |
|
| 700 | 0 |
_aAli Mamdouh Elashmawy , _eSupervisor |
|
| 700 | 0 |
_aHebat Allah Moustafa , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c45199 _d45199 |
||